96Y-12266-79296
2 vaccinations
9 coded responses
15 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 019 / MA
- Registered
- 2021-04-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-27
Dose 1 — Pfizer-BioNTech
-
2021-04-19
Registered in v-safe
-
2021-04-19
Dose 2 — Pfizer-BioNTech
-
2021-04-19
Survey response — day 0, dose 2MedDRA: Lip swelling, Pruritus — Feeling: Good · Site: Pain · Chills, Fatigue or tirednessFree text: Swollen lip and itchy face and neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Cough — Feeling: Good · Joint pains · Be unable to do your normal daily activitiesFree text: Dry coughingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Cough — Feeling: Good · Site: PainFree text: Dry coughingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Intense menstrual pain after months controlled with hormone, anti-spasm and anti-inflammatory medication.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Survey response — day 7, dose 2MedDRA: Dysmenorrhoea, Inflammation — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Intense menstruation pain and inflammation even with medication.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-03
-
2021-05-10
Survey response — day 21, dose 2MedDRA: Dermatitis, Hypersensitivity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Alergies, nasal and heightened dermatitis bouts.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Survey response — day 28, dose 2MedDRA: Hypersensitivity, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Severe allergy for over a week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-24
Survey response — day 35, dose 2MedDRA: Eye disorder, Hypersensitivity, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Ongoing allergy. Eyes got worse over the week, needing to get multiple meds and taking trips to the pharmacy. Very unusual in me. · Healthcare visit (other): Pharmacy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-24
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-02
- 2021-07-20
- 2021-10-18
- 2022-04-07
-
2022-04-12
Call successfulDoes not wish to fill out VAERS report
-
2022-04-25
Survey response — 12 months, dose 2MedDRA: Anxiety, Depression — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Depression and anxiety.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech |
Call center
3 call center cases
3 successful
1 wait over 3 months for a first call
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Swollen lip and itchy face and neck
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Dry coughing
Systemic reaction (other): Dry coughing
Systemic reaction (other): Intense menstrual pain after months controlled with hormone, anti-spasm and anti-inflammatory medication.
Release 8 — day 7, dose 2
Systemic reaction (other): Intense menstruation pain and inflammation even with medication.
Release 8 — day 21, dose 2
Symptoms: Alergies, nasal and heightened dermatitis bouts.
Release 8 — day 28, dose 2
Symptoms: Severe allergy for over a week.
Release 8 — day 35, dose 2
Symptoms: Ongoing allergy. Eyes got worse over the week, needing to get multiple meds and taking trips to the pharmacy. Very unusual in me.
Healthcare visit (other): Pharmacy.
Release 11 — 12 months, dose 2
Symptoms: Depression and anxiety.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Dermatitis | ✓ | ✓ | ✓ |
| SD | Eye disorder | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SRO | Inflammation | ✓ | ✓ | ✓ |
| SRO | Lip swelling | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release